0001415889-21-001607.txt : 20210322
0001415889-21-001607.hdr.sgml : 20210322
20210322190311
ACCESSION NUMBER: 0001415889-21-001607
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210319
FILED AS OF DATE: 20210322
DATE AS OF CHANGE: 20210322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAXE JON S
CENTRAL INDEX KEY: 0001114914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 21762560
MAIL ADDRESS:
STREET 1: FIRST HORIZON PHARMACEUTICAL CORP
STREET 2: 660 HEMBREE PKWY STE 106
CITY: ROSWELL
STATE: GA
ZIP: 30076
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-03222021_040300.xml
X0306
4
2021-03-19
0001411685
VistaGen Therapeutics, Inc.
VTGN
0001114914
SAXE JON S
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
Common Stock
2021-03-19
4
M
0
2500
1.50
A
5751
D
Common Stock
50000
I
By the Jon S. Saxe and Myrna G. Marshall 1997 Trust
Stock Option (Right to Buy)
1.50
2021-03-19
4
M
0
2500
0
D
2018-08-29
2021-04-26
Common Stock
2500
0
D
/s/ Jerrold D. Dotson, Attorney-in-Fact
2021-03-22